nach oben

International Journal of Clinical Oncology

Erschienen in:

04.10.2016 | Original Article

A population-specific correlation between ADIPOQ rs2241766 and rs 1501299 and colorectal cancer risk: a meta-analysis for debate

verfasst von: Lin Ye, Guobin Wang, Yong Tang, Jie Bai

Erschienen in: International Journal of Clinical Oncology | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Aims

Many epidemiological studies have investigated the correlation between adiponectin, C1Q and collagen domain containing (ADIPOQ) single nucleotide polymorphisms (SNPs) and risk of colorectal cancer (CRC). Although conflicting results have been reported, there was dispute regarding two SNPs (rs2241766 T/G and rs1501299 G/T). Therefore, we conducted a meta-analysis to systematically assess the associations and try to find the reasons for the dispute.

Methods

We searched PubMed, the Cochrane Library, Elsevier, Wiley Online Library, China National Knowledge Infrastructure, WanFang data and Chongqing VIP to search for all eligible case−control studies published up to January 2015. Effect sizes of odds ratios (OR) and 95 % confidence intervals (95 % CI) were calculated using a fixed- or random-effect model.

Results

Ten case–control studies including 4377 cases and 5584 controls were selected. A significant difference was observed in Chinese (OR 0.76; 95 % CI 0.68, 0.85; P < 0.001) and Ashkenazi Jewish populations (OR 0.79; 95 % CI 0.63, 0.99; P = 0.04) for rs2241766 with dominant model (TT vs TG + GG). A significant difference was observed in the Chinese population (OR 1.23; 95 % CI 1.11, 1.37; P < 0.001) for rs1501299 with dominant model (TT vs TG + GG). In addition, intake of red meat showed a synergistic effect between ADIPOQ gene and risk of colorectal cancer (CRC).

Conclusions

ADIPOQ SNPs rs2241766 T/G and rs 1501299 G/T have a population-specific correlation with risk of CRC. However, small sample studies may increase reporting bias, particularly if the total number of studies included in the analysis is small.

Cnop M, Havel PJ, Utzschneider KM et al (2003) Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46:459–469CrossRefPubMed

Gialamas SP, Petridou ET, Tseleni-Balafouta S et al (2011) Serum adiponectin levels and tissue expression of adiponectin receptors are associated with risk, stage, and grade of colorectal cancer. Metabolism 60:1530–1538CrossRefPubMed

Ye C, Wang J, Tan S et al (2013) Meta-analysis of adiponectin polymorphisms and colorectal cancer risk. Int J Med Sci 10:1113–1120CrossRefPubMedPubMedCentral

Li Q, Ma Y, Sang W et al (2014) Five common haplotype-tagging variants of adiponectin (ADIPOQ) and cancer susceptibility: a meta-analysis. Genet Test Mol Biomarkers 18:417–424CrossRefPubMedPubMedCentral

Xu Y, He B, Pan Y et al (2013) The roles of ADIPOQ genetic variations in cancer risk: evidence from published studies. Mol Biol Rep 40:1135–1144CrossRefPubMed

Ou Y, Chen P, Zhou Z et al (2014) Associations between variants on ADIPOQ and ADIPOR1 with colorectal cancer risk: a Chinese case-control study and updated meta-analysis. BMC Med Genet 15:137CrossRefPubMedPubMedCentral

Little J, Higgins JP, Ioannidis JP et al (2009) STrengthening the REporting of Genetic Association Studies (STREGA)–an extension of the STROBE statement. Genet Epidemiol 33:581–598CrossRefPubMed

Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558CrossRefPubMed

Higgins JP, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. BMJ 27:557–560CrossRef

10.

DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188CrossRefPubMed

11.

Demets DL (1987) Methods for combining randomized clinical trials: strengths and limitations. Stat Med 6:341–350CrossRefPubMed

12.

Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101CrossRefPubMed

13.

Egger M, Smith GD, Phillips AN (1997) Meta-analysis: principles and procedures. BMJ 315:1533–1537CrossRefPubMedPubMedCentral

14.

Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535CrossRefPubMedPubMedCentral

15.

Al-Harithy RN, Al-Zahrani MH (2012) The adiponectin gene, ADIPOQ, and genetic susceptibility to colon cancer. Oncol Lett 3:176–180PubMed

16.

Partida-Perez M, de la Luz Ayala-Madrigal M, Peregrina-Sandoval J et al (2010) Association of LEP and ADIPOQ common variants with colorectal cancer in Mexican patients. Cancer Biomark 7:117–121CrossRefPubMed

17.

Yi N, Kaklamani VG, Pasche B (2011) Bayesian analysis of genetic interactions in case-control studies, with application to adiponectin genes and colorectal cancer risk. Ann Hum Genet 75:90–104CrossRefPubMed

18.

Kaklamani VG, Wisinski KB, Sadim M et al (2009) Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. JAMA 300:1523–1531CrossRef

19.

Al Khaldi RM, Al Mulla F, Al Awadhi S et al (2011) Associations of single nucleotide polymorphisms in the adiponectin gene with adiponectin levels and cardio-metabolic risk factors in patients with cancer. Dis Markers 30:197–212CrossRefPubMedPubMedCentral

20.

Gornick MC, Rennert G, Moreno V, Gruber SB (2011) Adiponectin gene and risk of colorectal cancer. Br J Cancer 105:562–564CrossRefPubMedPubMedCentral

21.

Pechlivanis S, Bermejo JL, Pardini B et al (2009) Genetic variation in adipokine genes and risk of colorectal cancer. Eur J Endocrinol 160:933–940CrossRefPubMed

22.

Keku TO, Vidal A, Oliver S et al (2012) Genetic variants in IGF-I, IGF-II, IGFBP-3, and adiponectin genes and colon cancer risk in African Americans and Whites. Cancer Causes Control 23:1127–1138CrossRefPubMedPubMedCentral

23.

Tsilidis KK, Helzlsouer KJ, Smith MW et al (2009) Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer. Cancer Causes Control 20:1739–1751CrossRefPubMedPubMedCentral

24.

Zhang Y, Feng QL, Liu CM et al (2012) Relationship between polymorphism sites of adiponection and its receptor gene and the susceptibility of colorectal cancer [Chinese Article]. Jiangsu Daxue Xuebao (Yixueban) 22:336–341

25.

Guo X, Liu J, You L et al (2015) Association between adiponectin polymorphisms and the risk of colorectal cancer. Genet Test Mol Biomarkers 19:9–13CrossRefPubMedPubMedCentral

26.

Hu X, Yuan P, Yan J et al (2013) Gene Polymorphisms of +45T > G, -866G > A, and Ala54Thr on the risk of colorectal cancer: a matched case-control study. PLoS One 8:e67275CrossRefPubMedPubMedCentral

27.

Li X, Liu W, Feng F et al (2014) Association between adiponectin rs2241766, rs1501299 polymorphisms and the risk of colorectal cancer. Zhonghua Liu Xing Bing Xue Za Zhi 35:195–199PubMed

28.

Li P, Liu H, Li C et al (2014) An updated meta-analysis of the association between ADIPOQ rs2241766 polymorphism and colorectal cancer. Tumour Biol 35:2491–2496CrossRefPubMed

29.

Gonzalez-Sanchez JL, Zabena CA, Martinez-Larrad MT et al (2005) An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance. Obes Res 13:807–812CrossRefPubMed

30.

Carvajal-Carmona LG, Spain S, Consortium C et al (2009) Common variation at the adiponectin locus is not associated with colorectal cancer risk in the UK. Hum Mol Genet 18:1889–1892CrossRefPubMed

31.

Oostindjer M, Alexander J, Amdam GV et al (2014) The role of red and processed meat in colorectal cancer development: a perspective. Meat Sci 97:583–596CrossRefPubMed

32.

Ochoa MC, Santos JL, Azcona C et al (2007) Association between obesity and insulin resistance with UCP2–UCP3 gene variants in Spanish children and adolescents. Mol Genet Metab 92:351–358CrossRefPubMed

33.

de Luis DA, Sagrado MG, Aller R et al (2009) Ala54Thr polymorphism of fatty acid binding protein 2, role on insulin resistance and cardiovascular risk factors in presurgical morbid obesity patients. Obes Surg 19:1691–1696CrossRefPubMed

34.

Yoon YS, Keum N, Zhang X et al (2015) Hyperinsulinemia, insulin resistance and colorectal adenomas: a meta-analysis. Metabolism 64:1324–1333CrossRefPubMed

35.

Melistas L, Mantzoros CS, Kontogianni M et al (2009) Association of the +45T > G and +276G > T polymorphisms in the adiponectin gene with insulin resistance in nondiabetic Greek women. Eur J Endocrinol 161:845–852CrossRefPubMedPubMedCentral

Titel: A population-specific correlation between ADIPOQ rs2241766 and rs 1501299 and colorectal cancer risk: a meta-analysis for debate
verfasst von: Lin Ye
Guobin Wang
Yong Tang
Jie Bai
Publikationsdatum: 04.10.2016
Verlag: Springer Japan
Erschienen in: International Journal of Clinical Oncology / Ausgabe 2/2017
Print ISSN: 1341-9625
Elektronische ISSN: 1437-7772
DOI: https://doi.org/10.1007/s10147-016-1044-3

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

A population-specific correlation between ADIPOQ rs2241766 and rs 1501299 and colorectal cancer risk: a meta-analysis for debate

Abstract

Aims

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Aims

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2017

Clinical outcomes of second transurethral resection in non-muscle invasive high-grade bladder cancer: a retrospective, multi-institutional, collaborative study

Recent progress and perspectives on prostate cancer biomarkers

Oncologic and obstetric outcomes and complications during pregnancy after fertility-sparing abdominal trachelectomy for cervical cancer: a retrospective review

Clinical outcomes of stage IV colorectal cancer after R0 resection: a multi-institutional retrospective analysis

Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study

Breakthrough chemotherapy-induced nausea and vomiting: report of a nationwide survey by the CINV Study Group of Japan

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie